New Low-Cost HPV test could save lives in poor countries

NCT ID NCT07538050

Recruiting now Diagnosis Sponsor: The Cleveland Clinic Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 04, 2026 · Updated 3 times

Summary

This study tests a low-cost HPV test that can be done in one visit, so women get results and treatment on the same day. It aims to reduce the number of women lost to follow-up in cervical cancer screening programs. The study will enroll 1,000 women in remote areas of El Salvador.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: low-cost HPV test (ScreenFire)
What this could lead to: If successful, this could make cervical cancer screening more accessible in low-resource areas, reducing deaths from the disease.
What could go wrong: This is a small, early-stage study in one country. The test may not work as well in other settings, and same-day treatment may not be feasible everywhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER SCREENING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER SCREENING

Contacts and locations

Locations

Ministry of Health Clinics
RECRUITING

San Salvador, Oriente, 000000000, El Salvador

More trials for these conditions

Other studies related to the condition(s) this trial covers.